The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harlin, H.
Right arrow Articles by Alegre, M.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harlin, H.
Right arrow Articles by Alegre, M.-L.
The Journal of Immunology, 2002, 169: 2451-2459.
Copyright © 2002 by The American Association of Immunologists

TCR-Independent CD30 Signaling Selectively Induces IL-13 Production Via a TNF Receptor-Associated Factor/p38 Mitogen-Activated Protein Kinase-Dependent Mechanism1

Helena Harlin*, Eckhard Podack{ddagger}, Mark Boothby§ and Maria-Luisa Alegre2,*,{dagger}

* Committee on Immunology and {dagger} Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637; {ddagger} Department of Microbiology and Immunology, University of Miami, Miami, FL 33101; and § Department of Microbiology and Immunology, Vanderbilt University Medical School, Nashville, TN 37232

Initiation of T lymphocyte responses to most Ags requires concurrent stimulation through the TCR and costimulatory receptors such as CD28. Following initial activation, secondary receptors are up-regulated that can costimulate T cells in concert with TCR engagement. One such receptor is the TNFR family member CD30. In this study, we report that unlike CD28, ligation of CD30 on normal effector T cells induces IL-13 production in the absence of concurrent TCR engagement. TCR-independent CD30-mediated IL-13 release correlated with activation of c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), and NF-{kappa}B, and was completely inhibited by the expression of a TNFR-associated factor 2 (TRAF2) dominant-negative transgene (TRAF2.DN-Tg), but not by that of an I-{kappa}B{alpha} dominant-negative transgene. In parallel, expression of the TRAF2.DN-Tg selectively prevented the induction of c-Jun N-terminal kinase and p38 MAPK, but not that of NF-{kappa}B. Furthermore, IL-13 production was reduced in a dose-dependent manner by the p38 MAPK inhibitor SB203580. Together, these results suggest that TCR-independent CD30-mediated production of IL-13 is triggered by association of CD30 with TRAF family members and subsequent activation of p38 MAPK. Inasmuch as IL-13 can promote airway inflammation and cancer progression, production of IL-13 in a TCR-independent manner has important pathological implications in vivo.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Tang, H. Yamada, K. Shibata, H. Muta, W. Wajjwalku, E. R. Podack, and Y. Yoshikai
A Novel Role of CD30L/CD30 Signaling by T-T Cell Interaction in Th1 Response against Mycobacterial Infection
J. Immunol., November 1, 2008; 181(9): 6316 - 6327.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. N. H. Stern, D. B. Keskin, H. Zhang, H. Lv, Z. Kato, and J. L. Strominger
Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice
PNAS, April 1, 2008; 105(13): 5172 - 5176.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S.-Y. Nam, Y.-H. Kim, J.-S. Do, Y.-H. Choi, H.-J. Seo, H.-K. Yi, P.-H. Hwang, C.-H. Song, H.-K. Lee, J.-S. Kim, et al.
CD30 supports lung inflammation
Int. Immunol., February 1, 2008; 20(2): 177 - 184.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. V. Krysov, T. F. Rowley, and A. Al-Shamkhani
Inhibition of p38 mitogen-activated protein kinase unmasks a CD30-triggered apoptotic pathway in anaplastic large cell lymphoma cells
Mol. Cancer Ther., February 1, 2007; 6(2): 703 - 711.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Gao, P. Schwartzberg, J. A. Wilder, B. R. Blazar, and D. Yuan
B Cell Induction of IL-13 Expression in NK Cells: Role of CD244 and SLAM-Associated Protein.
J. Immunol., March 1, 2006; 176(5): 2758 - 2764.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Watanabe, M. Sasaki, K. Itoh, M. Higashihara, K. Umezawa, M. E. Kadin, L. J. Abraham, T. Watanabe, and R. Horie
JunB Induced by Constitutive CD30-Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase Signaling Activates the CD30 Promoter in Anaplastic Large Cell Lymphoma and Reed-Sternberg Cells of Hodgkin Lymphoma
Cancer Res., September 1, 2005; 65(17): 7628 - 7634.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. R. Blazar, R. B. Levy, T. W. Mak, A. Panoskaltsis-Mortari, H. Muta, M. Jones, M. Roskos, J. S. Serody, H. Yagita, E. R. Podack, et al.
CD30/CD30 Ligand (CD153) Interaction Regulates CD4+ T Cell-Mediated Graft-versus-Host Disease
J. Immunol., September 1, 2004; 173(5): 2933 - 2941.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. So, S. Salek-Ardakani, H. Nakano, C. F. Ware, and M. Croft
TNF Receptor-Associated Factor 5 Limits the Induction of Th2 Immune Responses
J. Immunol., April 1, 2004; 172(7): 4292 - 4297.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
I. Dozmorov, M. R. Saban, N. Knowlton, M. Centola, and R. Saban
Connective molecular pathways of experimental bladder inflammation
Physiol Genomics, November 11, 2003; 15(3): 209 - 222.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. M. Reyes, J. R. Walker, C. DeCino, J. B. Hogenesch, and P. E. Sawchenko
Categorically Distinct Acute Stressors Elicit Dissimilar Transcriptional Profiles in the Paraventricular Nucleus of the Hypothalamus
J. Neurosci., July 2, 2003; 23(13): 5607 - 5616.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.